Alliança Saúde, previously controlled by investor Nelson Tanure, has officially withdrawn its proposal to purchase 18 units of the Meddi Group, which focuses on diagnostic laboratories and vaccination services mainly in Bahia. This withdrawal was submitted to CADE (Administrative Council for Economic Defense) after the request had been pending since October of the previous year, with a valuation of R$ 252 million.

The decision to shelve the acquisition comes on the heels of inquiries from CADE regarding potential structural changes within Alliança and uncertainties surrounding its economic-financial condition. These concerns emerged after reports surfaced suggesting that Tanure may have been negotiating a sale of Alliança to manage debts linked to his purchase of Ligga Telecom, alongside delays in payments to medical and support staff.

This development signifies a pause in Alliança Saúde's expansion plans in Brazil's Northeast region, which could have implications for its competitive positioning in the healthcare sector, especially against a backdrop where financial stability and regulatory approval are critical for such acquisitions. The outcome of this situation will be vital for gauging both Alliança’s future initiatives and the overall market dynamics in healthcare acquisitions in Brazil.